Federal Register / Vol. 77, No. 183 / Thursday, September 20, 2012 / Notices 58393 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: September 6, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–23162 Filed 9–19–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ Patient Centered 

Outcomes Research (PCOR) Pathway to 

Independence Award (K99/ROC)’’ 

DATES: November 1, 2012 (Open on 

November 1 from 8:00 a.m. to 8:30 a.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Hyatt Regency Hotel 

Bethesda, One Metro Center, Bethesda, 

MD 20814. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

‘‘AHRQ Patient Centered Outcomes 

Research (PCOR) Pathway to 

Independence Award (K99/R00)’’ are to 

be reviewed and discussed at this 

meeting. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Dated: September 13, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–23166 Filed 9–19–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of five AHRQ 

subcommittee meetings. 

SUMMARY: The subcommittees listed 

below are part of AHRQ’s Health 

Services Research Initial Review Group 

Committee. Grant applications are to be 

reviewed and discussed at these 

meetings. These meetings will be closed 

to the public in accordance with 5 

U.S.C. App. 2 section 10(d),’5 U.S.C. 

section 552b(c)(4), and 5 U.S.C. section 

552b(c)(6). 

DATES: See below for dates of meetings: 

1. Health Care Research Training 

Date: October 11–12, 2012 (Open from 

8:30 a.m. to 8:45 a.m. on October 11 

and closed for remainder of the 

meeting) 

2. Healthcare Effectiveness and 

Outcomes Research 

Date: October 16–17, 2012 (Open from 

8:30 a.m. to 8:45 a.m. on October 16 

and closed for remainder of the 

meeting) 

3. Health Systems and Value Research 

Date: October 24, 2012 (Open from 

8:30 a.m. to 8:45 a.m. on October 24 

and closed for remainder of the 

meeting) 

4. Healthcare Information Technology 

Research 

Date: October 25, 2012 (Open from 

8:30 a.m. to 8:45 a.m. on October 25 

and closed for remainder of the 

meeting) 

5. Healthcare Safety and Quality 

Improvement Research 

Date: October 31, 2012 (Open from 

8:30 a.m. to 8:45 a.m. on October 31 

and closed for remainder of the 

meeting) 

ADDRESSES: The five meetings will take 

place in the same location: 

Hyatt Regency Hotel Bethesda, 

One Metro Center, 

Bethesda, MD 20814. 

FOR FURTHER INFORMATION CONTACT: (To 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of the meetings.) 

Mrs. Bonnie Campbell, Committee 

Management Officer, Office of 

Extramural Research Education and 

Priority Populations, AHRQ 540, 

Gaither Road, Suite 2000, Rockville, 

Maryland 20850, Telephone (301) 

427–1554. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10 (a)(2) of the 

Federal Advisory Committee Act (5 

U.S.C. App. 2), AHRQ announces 

meetings of the scientific peer review 

groups listed above, which are 

subcommittees of AHRQ’s Health 

Services Research Initial Review Group 

Committee. The subcommittee meetings 

will be closed to the public in 

accordance with the provisions set forth 

in 5 U.S.C. App. 2 section 10(d), 5 

U.S.C. 552b(c)(4), and 5 U.S.C. 

552b(c)(6). The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

mstockstill on DSK4VPTVN1PROD with NOTICES

58394 Federal Register / Vol. 77, No. 183 / Thursday, September 20, 2012 / Notices 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: September 6, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–23164 Filed 9–19–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-12–12RO] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 and 

send comments to Kimberly S. Lane, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an email to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Anniston Community Health Survey: 

Follow-up and Dioxin Analyses (ACHS– 

II)—New—Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (DHHS) Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

In the past, polychlorinated biphenyls 

(PCBs) were used as coolants and 

lubricants in electrical equipment. They 

didn’t burn easily and were good 

insulators. PCBs are no longer made in 

the U.S. They were banned in 1977 

because they persist in the environment. 

Concerns grew about harm to health. 

The City of Anniston, AL, was the site 

of the former Monsanto facility. PCBs 

were made there from 1929 to 1971. For 

decades, PCBs were released into the 

local air, soil, and surface water. In 

1996, residents found out they were 

exposed. Concerns grew and led to 

litigation. In 2003, a settlement in favor 

of the residents was reached in state and 

federal courts. 

The Anniston Environmental Health 

Research Consortium (AEHRC) was 

funded by the Agency for Toxic 

Substances and Disease Registry 

(ATSDR). The AEHRC conducted the 

Anniston Community Health Survey 

(ACHS) from 2005 to 2007. Serum PCB 

levels in 766 Anniston adults were 

found to be three to seven times higher 

than in U.S. adults. Also, higher PCB 

levels were found in Anniston adults 

who had high blood pressure and 

diabetes. 

The ATSDR and the National 

Institutes of Health (NIH) plan to 

continue the work of the first ACHS. 

These agencies will conduct a follow-up 

study called the ACHS–II. It will be a 

repeated cross-sectional study. Data 

collection will be managed by the 

University of Alabama at Birmingham 

(UAB) and the Calhoun County Health 

Department (CCHD). 

A sample of 500 adults will be 

selected from the first ACHS cohort. 

After informed consent, clinical 

assessments will be done. These will be 

for blood pressure, height, weight, and 

body girth. A questionnaire will be 

answered by computer-assisted personal 

interviews (CAPIs). Questions will be 

asked for health, demographic, diet, and 

lifestyle factors. The self-reported 

responses will be compared to 

laboratory analytes. For these, blood 

samples will be drawn and analyzed. 

The ACHS–II will measure the same 

serum PCBs as in the first Anniston 

survey. In this way, changes in PCB 

levels can be studied. The ACHS–II will 

also include serum analytes for dioxins, 

furans, dioxin-like PCBs, and other 

similar chemicals. Additional analytes 

include blood measures of heavy metals. 

Clinical biomarkers will include 

measures for thyroid, diabetes, lipids, 

and immune function. This will give a 

more complete profile of human 

exposures and health in Anniston, AL. 

The ATSDR is requesting a two-year 

approval for this information collection. 

There are no costs to respondents 

other than their time. In total, they will 

spend 2 hours in the study. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hrs) 

Total burden 

hours 

Adults who took part in first Anniston Community 

Health Survey.

Telephone Recruitment 

Script.

333 1 2/60 11 

Survey for Refusals ...... 165 1 1/60 3 

Informed Consent ......... 250 1 1/60 4 

Update Contact Information Form.250 1 1/60 4 

Medications Form ......... 250 1 3/60 12 

Blood Draw Form ......... 250 1 2/60 8 

Questionnaire ............... 250 1 45/60 188 

Total ............................................................... ....................................... ........................ ........................ ........................ 230 

mstockstill on DSK4VPTVN1PROD with NOTICES